Catalio Capital Management, LP Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$457.1B

Holdings

33

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (33 positions)

#StockSharesValue% PortfolioType
1
BDXBECTON DICKINSON & CO
148,615$33.7B7.38%
2
ASNDASCENDIS PHARMA A/S
215,587$29.7B6.49%
3
BMYBRISTOL-MYERS SQUIBB CO
499,151$28.2B6.18%
4
SWTXSPRINGWORKS THERAPEUTICS INC
764,668$27.6B6.04%
5
2L9BLUEPRINT MEDICINES CORP
284,654$24.8B5.43%
6
EWEDWARDS LIFESCIENCES CORP
333,144$24.7B5.40%
7
BBIOBRIDGEBIO PHARMA INC
898,458$24.7B5.39%
8
LIVNLIVANOVA PLC
512,447$23.7B5.19%
9
SEPNSEPTERNA INC
1,024,245$23.5B5.13%
10
CYTKCYTOKINETICS INC
457,587$21.5B4.71%
11
NVSTENVISTA HOLDINGS CORPORATION
1,019,529$19.7B4.30%
12
VCYTVERACYTE INC
490,547$19.4B4.25%
13
ISRGINTUITIVE SURGICAL INC
36,910$19.3B4.21%
14
EXASEXACT SCIENCES CORP
309,103$17.4B3.80%
15
DNTHDIANTHUS THERAPEUTICS INC
763,471$16.6B3.64%
16
QUREUNIQURE NV
901,973$15.9B3.48%
17
GPCRSTRUCTURE THERAPEUTICS INC
569,395$15.4B3.38%
18
3M4MASIMO CORP
87,377$14.4B3.16%
19
IRONDISC MEDICINE INC
179,815$11.4B2.49%
20
ADMAADMA BIOLOGICS INC
512,724$8.8B1.92%
21
NARIUSDINARI MED INC
132,545$6.8B1.48%
22
BSXBOSTON SCIENTIFIC CORP
72,925$6.5B1.42%
23
KROSKEROS THERAPEUTICS INC
407,292$6.4B1.41%
24
TARAPROTARA THERAPEUTICS INC
1,088,691$5.7B1.26%
25
MERSANA THERAPEUTICS INC
1,705,036$2.4B0.53%
26
KYTXKYVERNA THERAPEUTICS INC
586,909$2.2B0.48%
27
MGXMETAGENOMI INC
528,993$1.9B0.42%
28
KPTIEURKARYOPHARM THERAPEUTICS INC
2,334,375$1.6B0.35%
29
ZBIOZENAS BIOPHARMA INC
187,184$1.5B0.34%
30
HYPRHYPERFINE INC
760,035$668.8M0.15%
31
GUTSFRACTYL HEALTH INC
214,236$441.3M0.10%
32
ATAIATAI LIFE SCIENCES NV
196,858$261.8M0.06%
33
SNSEEURSENSEI BIOTHERAPEUTICS INC
294,374$144.3M0.03%